đź§  Neurosurgeon-Scientist @NeurosurgeryUSC | Editor, Neurosurgical Focus | Vice Chair, Education | Director @USCBTC Advancing #BrainTumor & #Pituitary care

Los Angeles, CA
Gabriel Zada, MD, MS retweeted
Radiotherapy after surgery halves risk of recurrence in a type of brain tumour that can often grow back, trial shows. Find out more in The Lancet: spkl.io/60137TUFS #EANO2026
6
52
139
26,449
Gabriel Zada, MD, MS retweeted
🚨 TUMOR WARS III: Neuro-Onc Jeopardy 🧠⚡ The showdown returns! Med students, residents & fellows will compete in a fast-paced neuro-onc Jeopardy battle. 👉 Register: forms.gle/pY27qDL6pVb9XsMo9
1
2
9
845
This new research found that #Meningiomas exhibit a significant association between their #anatomical origin and #chromosomal #alterations. Read the full article here: thejns.org/focus/view/journa…
4
11
703
Gabriel Zada, MD, MS retweeted
Great first year for the Research Update in Neuroscience for Neurosurgeons (#RUNN) course at Asilomar in Pacific Grove, CA, after many years at Woods Hole, MA.  A full house of neurosurgery trainees with great questions. I had the chance to talk about convective delivery for nervous system gene therapy. The residents and fellows in that room are the ones who will carry this from clinical trials into everyday practice. With trainees like these, the future of the field is bright. @OSUGeneTherapy @OhioStateMed @NeurosurgeryOSU #Neurosurgery #GeneTherapy #ConvectionEnhancedDelivery #Neuroscience #Asilomar #PacificGrove #OhioState
1
5
36
5,585
The 2026 SNS RUNN Course has begun! We look forward to a week of equipping neurosurgical trainees with basic knowledge & connections to advance impactful research across the neurosciences. #SNS #RUNNCourse
6
21
1,456
The topic of the September issue of #NeurosurgicalFocus is around #Meningiomas: Emerging Insights and Management Implications, with Wenya Linda Bi, Stephen Magill, Jennifer Moliterno, @FarshadNassiri, Soichi Oya, and Michel Kalamarides as editors. thejns.org/focus/view/journa…
3
9
840
Gabriel Zada, MD, MS retweeted
Dr. Gabriel Zada, Editor of Neurosurgical Focus, gives an overview of the September 2026 issue: vimeo.com/1223757089
3
21
2,564
Gabriel Zada, MD, MS retweeted
A second chance can become an opportunity to make a difference. After surviving a brain tumor, one survivor is using his experience to spread hope, encourage others, and remind the brain tumor community of the power of sharing our stories. Read his inspiring story on MindMatters: abta.org/mindmatters/brain-t… #braincancer #braintumorsurvivor #braintumor #survivorstories
2
3
421
🧬 New in @NatureRevEndo — Pituitary Society International Consensus Statement on genetic testing in pituitary adenomas. @PituitarySoc Evidence-based guidance on which germline genes to include on a panel (AIP, MEN1, CDKN1B, PRKAR1A, SDHx, MAX, GPR101, GNAS), who to test, how to counsel and interpret results, and when somatic testing is worth considering in aggressive PAs. Key takeaway: genetic testing is now a real adjunct in pituitary care — best delivered by a multidisciplinary team with endocrine, genetics, and lab expertise. 🔗 doi.org/10.1038/s41574-026-0… #Pituitary #Neurosurgery #Endocrinology #PrecisionMedicine #Genetics​​​​​​​​​​​​​​​​ @MariaFleseriu @MelmedShlomo
1
9
33
1,783
Gabriel Zada, MD, MS retweeted
Replying to @TheJNS
@TheJNS is now accepting papers for the May 2027 issue of Neurosurgical Focus on Advocacy & Policy! Don't delay, submit today! Submissions are due no later than Nov. 1. For more info about the topic and/or to submit your paper, visit the JNSPG website👇 thejns.org/page/call-for-pap…
9
18
3,559
New publication in @TheJNS 🧠 Our multicenter international study of 162 patients with Cushing’s disease shows that endoscopic endonasal surgery achieves excellent resection + durable disease control. Early postop cortisol is a powerful predictor of long-term outcome. ▪️ Gross-total resection in 86.4% of cases — rising to 91.9% in tumors without cavernous sinus invasion ▪️ Hormonal remission in 78.4% at follow-up 29.8 months ▪️ POD1 cortisol <2 µg/dL predicted a 91.8% recurrence-free survival rate ▪️ No visual or vascular complications + no mortalities across the series A collaborative effort across University of Naples Federico II, @USC + the Medical University of Vienna, providing practical data to refine postoperative risk stratification for patients with Cushing’s disease. Proud of our former USC fellows @ilariabove and @AlexMickoMD, and grateful to all our collaborators. Link: doi.org/10.3171/2026.3.jns25… #Neurosurgery #Pituitary #Endocrinology #PituitaryTumor #SkullBase @uscpituitarycenter @uscbtc #medtwitter
8
20
1,362
Great collaboration! 🙏🏼 @TheJNS
#HotOffThePress Our IRRF study showed that SRS is a safe and effective management strategy for elderly patients with vestibular schwannoma. @UAMSneurosurg @PittNeurosurg @PittCIGNS @IntRRF @TheJNS thejns.org/view/journals/j-n…
1
16
1,527
Gabriel Zada, MD, MS retweeted
Multiple surgeons told Karen Ross that the surgical removal of her benign meningioma was not possible. That changed when she found the treatment plan she had been looking for at the USC Brain Tumor Center. Read here: uscne.ws/btc
17
13
104
22,162
Thank you Dr. Thakur for this thoughtful contribution to Neurosurgical Focus. @TheJNS #Neurosurgery #Medicine #Surgery
While we see numerous profoundly rewarding tranformative experiences as a neurosurgeon; every neurosurgery provider have been witness to devastating clinical scenarios and makes you experience “Grief” from a unique dimmension. You see the grief of the patient, patient caregivers, providers attached to the care of the patient and witness your own. Our team of Neurosurgeons, Engineers, SKY Breath Meditation Facilatators, Sound Alchemist and Advanced Practice Providers come together to discuss the Grief seen in the circle of Neurosurgery through this paper in JNS Focus. We illuminate the potential role of “Ikigai”, teachings of non dualistic philosophy of Ashtavakra Gita and SKY Breath meditation practices in handling grief. @jmp9782 @jacquesmorcosmd @TheJNS @DoctorZada @Gurudev @ajtejasvi @Bhanujgd #grief #neurosurgery #skybreath #ikigai
2
2
17
3,032
Gabriel Zada, MD, MS retweeted
#Grief in #Neurosurgery. A critical topic not discussed or taught much. I co-edited an entire issue on it: thejns.org/focus/view/journa… AMAZING collection of papers all should read. Read my own thoughts in this Editorial: thejns.org/focus/view/journa…. @AANSNeuro @TheJNS @CNS_Update
2
23
80
8,340
Gabriel Zada, MD, MS retweeted
Replying to @jacquesmorcosmd
@jacquesmorcosmd strikes again. A beautifully articulated essay on grief by a seasoned neurosurgeon. A thoughtful and deeply moving reflection on something we all encounter but rarely discuss openly. A must-read.
#Grief in #Neurosurgery. A critical topic not discussed or taught much. I co-edited an entire issue on it: thejns.org/focus/view/journa… AMAZING collection of papers all should read. Read my own thoughts in this Editorial: thejns.org/focus/view/journa…. @AANSNeuro @TheJNS @CNS_Update
2
34
3,198
Gabriel Zada, MD, MS retweeted
Published this week @NatureMedicine, B7-H3 CAR T cells show promise in patients with rGBM! Congrats to all authors for another big step forward for our field. nature.com/articles/s41591-0…
2
19
101
12,048
Neurosurgeons from different parts of the world deal differently with complications: - Our European colleagues were more likely to question their clinical abilities and less likely to admit fault to the patient every time - US neurosurgeons were more frequently implicated in litigation and were more likely to utilize faith, mindfulness, and therapy - The principle of forgive and remember provides a constructive framework facilitating moving forward, while remembering and learning from complications. Great work by our brilliant research fellow @VictorGabriel_H @TJUHNeurosurg, having our artwork on the cover of the journal was the icing on the cake! @TheJNS
1
7
54
4,758